Renascience (TSE:4889) Days Payable: 0.00 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4889 Renascience Inc TSE:4889
53 GF Score
Price 円1,522.00
GF Value 円331.42
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Renascience Days Payable?

Renascience TSE:4889 -2.25% 53 Days Payable is 0.00 as of Mar. 2026. GuruFocus rates TSE:4889 with a GF Score™ of 53/100 and a GF Value™ of 円331.42 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Renascience ranks worse than 125786.04% on this metric.

Renascience's average Accounts Payable for the six months ended in Mar. 2026 was 円0.00 Mil. Renascience's Cost of Goods Sold for the six months ended in Mar. 2026 was 円2.77 Mil. Hence, Renascience's Days Payable for the six months ended in Mar. 2026 was 0.00.

The historical rank and industry rank for Renascience's Days Payable or its related term are showing as below:

TSE:4889's Days Payable is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 67.87
* Ranked among companies with meaningful Days Payable only.

Renascience's Days Payable stayed the same from Mar. 2025 (0.00) to Mar. 2026 (0.00).

Renascience Days Payable Historical Data

* Premium members only.

The historical data trend for Renascience's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Renascience Days Payable Chart

Renascience Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Days Payable
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Renascience Semi-Annual Data
Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

TSE:4889 vs ABT, SYK, MDT: Days Payable Comparison

For the Medical Devices subindustry, Renascience's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Renascience Days Payable vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Renascience's Days Payable distribution charts can be found below:

* The bar in red indicates where Renascience's Days Payable falls into.


TSE:4889
53GF Score
Renascience Inc TSE:4889
Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Renascience Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Renascience's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as

Days Payable (A: Mar. 2026 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Mar. 2025 ) + Accounts Payable (A: Mar. 2026 )) / count ) / Cost of Goods Sold (A: Mar. 2026 )*Days in Period
=( (0 + 0) / 1 ) / 4.347*365
=0 / 4.347*365
=0.00

Renascience's Days Payable for the quarter that ended in Mar. 2026 is calculated as:

Days Payable (Q: Mar. 2026 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Sep. 2025 ) + Accounts Payable (Q: Mar. 2026 )) / count ) / Cost of Goods Sold (Q: Mar. 2026 )*Days in Period
=( (0 + 0) / 1 ) / 2.766*365 / 2
=0 / 2.766*365 / 2
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 0.00 mean?
Renascience (TSE:4889) has a Days Payable of 0.00 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Renascience and its competitors. According to the industry distribution chart, Renascience ranks #999999 out of 795 companies in the Medical Devices & Instruments industry.
Is Renascience's Days Payable too high?
Renascience's current Days Payable is 0.00. Based on the distribution chart, Renascience ranks #999999 out of 795 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Renascience has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Renascience's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Renascience ranks #999999 out of 795 companies for Days Payable. This places Renascience in the lower half of its industry. The industry median Days Payable is 67.87. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Renascience and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Renascience's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Renascience stock overvalued right now?
Based on GuruFocus' analysis, Renascience (TSE:4889) is currently considered Significantly Overvalued. The stock's GF Value™ is 円331.42, compared to a current price of 円1,522.00 — trading 359.2% above its estimated fair value. The current Days Payable is 0.00. Renascience's overall GF Score™ is 53/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Renascience (TSE:4889), the current Days Payable is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Renascience (TSE:4889) Overvalued in 2026?

Based on GuruFocus' analysis, Renascience stock appears to be overvalued. The current stock price of 円1,522.00 is trading 359.2% above its estimated GF Value™ of 円331.42. GuruFocus considers Renascience to be Significantly Overvalued.

Key valuation signals for TSE:4889:

  • Days Payable: 0.00
  • GF Value™: 円331.42 vs. price of 円1,522.00 (359.2% above fair value)
  • GF Score™: 53/100 with 3 warning signs

No single metric tells the full story. See the TSE:4889 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Renascience Business Description

Address 2-1 Seiryo-cho, Aoba-ku, Miyagi, Sendai, JPN, 103-0023
Renascience Inc is engaged in the Development and commercialization of pharmaceuticals, medical devices, pieces of software as a medical device (SaMD) utilizing AI, etc.
53GF Score

Get the complete analysis for TSE:4889

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,522.00
Price
円331.42
GF Value